Queens Wharf investors refunded millions after contracts cancelled
Investors in a luxury tower at Queens Wharf have been refunded millions of dollars in deposits, with interest, after the developer confirmed the project faces three-year delays.
Investors in a luxury tower at Queens Wharf have been refunded millions of dollars in deposits, with interest, after the developer confirmed the project faces three-year delays.
Australian retail supremo Solomon Lew had a first-hand view of how the now two-time US President tackled business deals and it offers plenty of lessons for leaders.
The regulator’s blockbuster action against the casino’s former directors is about to start. And the stakes couldn’t be higher.
After years of trailing Victoria and Queensland, the NSW build-to-rent investment market is taking off, a report by Knight Frank’s Australia says.
Game developer Mighty Kingdom has raised money at an onerous rate to keep the lights on but says it is still working on corporate opportunities which could deliver value.
News Corp will have a stronger earnings profile and be better focused on its digital property growth drivers following the sale of Foxtel to DAZN, Goldman Sachs says.
New ownership for subscription giant Foxtel and its hit brands Kayo and BINGE is set to shake up Australia’s media and sport landscape.
The UK sports streaming operator has big plans for the way the world watches sport – and Foxtel is set to become a key part of this.
A Melbourne med-tech start-up at the centre of a court fight has fallen into administration, as the company’s co-founder lobbed a shot at Victoria’s $2bn venture capital fund.
David Sipina, who promoted the fraudulent Courtenay House Ponzi scheme which left creditors owed more than $50m, has avoided jail time after pleading guilty.
Incitec Pivot says it will forge ahead with asset sales next year, while at the same time warning earnings will take a hit from investment in plant.
Barefoot Investor tried to uncover Facebook’s fake Scott Pape scammers but it all descended into chaos with his wife away, the kids sick and German backpackers running his farm.
Qantas, Woolworths and now ANZ have all found out the hard way. On reputation – you go up slowly but come down at high speed.
The company has received US Food and Drug Administration approval for its drug Ryoncil, in a stunning turnaround from a year ago, when the same drug tanked the share price.
Original URL: https://www.dailytelegraph.com.au/business/victoria-business/page/7